Sustainability: Pharma Reaches Above the Low-Hanging Fruit

Those who cover green and sustainability issues know that Pharma is pretty progressive. No, the industry's not perfect, certainly, but many of its leading companies also make it a point to be leaders in environmental stewardship. While more drug companies are successfully jumping on the green bandwagon, it's getting harder and harder to find projects that make a real difference. In other words, the low-hanging fruit has been picked. So what's next?

In Pharmaceutical Manufacturing's May cover story, we look at what's next--five projects from five companies who are leaders in sustainability: AstraZeneca, Pfizer, Bayer, DSM Pharmaceutical Products, and EMD Millipore. These are just a few of the companies that continue to embrace green as a marketing strategy, as a competitive advantage, and as the right thing to do.

Also in our May issue, co-authors from Biogen Idec and Veolia talk about a combined heat and power (CHP) project they recently undertook. Here are links below--enjoy the fruits of our labor.

Cover Story:

Pharma Sustainability Is on a Roll

Sidebars:

EMD Millipore: Giving and Receiving Single-Use Systems

Bayer: Keeping Data Cold and Green

Pfizer Newbridge Powers Up

Feature:

Biogen and Veolia: Optimizing the Energy Efficiency of Research and Manufacturing Processes

 

--Paul Thomas